Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2174/1871526520999201126203510 http://scihub22266oqcxt.onion/10.2174/1871526520999201126203510 33243134!ä!33243134 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Infect+Disord+Drug+Targets 2021 ; 21 (6): e170721188439 Nephropedia Template TP {{tp|p=33243134|t=2021. COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases |pdf=|usr=}}{{33243134}} gab.com Text COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases JO: Infect Disord Drug Targets http://www.kidney.de/pget.php?&tw=1&pmid=33243134 #FOAvip BACKGROUND: Azithromycin has been considered as a possible therapeutic agent for COVID-19 patients. However, there is limited data on its efficacy. CASE PRESENTATION: We describe three patients diagnosed with COVID-19 who did not respond to the initial treatment but improved dramatically upon adding azithromycin with a successful outcome. CONCLUSION: We have presented evidence of the potential beneficial effect of the azithromycin in the treatment of patients with COVID-19 in three different clinical settings. More evidence is needed regarding the microbiological data, safety, and efficacy of this medication in the management of COVID-19. Twit Text FOAVip COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases ????Infect Disord Drug Targets http://www.kidney.de/pget.php?&tw=1&pmid=33243134 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33243134 #FOAvip English Wikipedia <ref>{{Cite pmid|33243134}}</ref> COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases #MMPMID33243134 Ghiasvand F; Ghadimi M; Sadr S; Jafari F; Manafi N; Ahmadinejad Z; Tirgar S; Seyed Alinaghi SA Infect Disord Drug Targets 2021[]; 21 (6): e170721188439 PMID33243134show ga BACKGROUND: Azithromycin has been considered as a possible therapeutic agent for COVID-19 patients. However, there is limited data on its efficacy. CASE PRESENTATION: We describe three patients diagnosed with COVID-19 who did not respond to the initial treatment but improved dramatically upon adding azithromycin with a successful outcome. CONCLUSION: We have presented evidence of the potential beneficial effect of the azithromycin in the treatment of patients with COVID-19 in three different clinical settings. More evidence is needed regarding the microbiological data, safety, and efficacy of this medication in the management of COVID-19. |*Azithromycin/therapeutic use[MESH] |*COVID-19 Drug Treatment[MESH] |Humans[MESH] |Hydroxychloroquine[MESH]COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Rep(epmc).pdf DeepDyve Pubget Overpricing